Human Immunodeficiency Virus Infection
📧 Sign up to get email alerts when something new happens for Human Immunodeficiency Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Randomized Trial of an HIV Prevention and Relationship Education Program for Young Male Couples [Phase 2]
A Phase 2 randomized trial evaluating an HIV prevention and relationship education program for young male couples has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: Positive Attitudes Concerning Infant Feeding- a Questionnaire for Women Living With HIV
Study evaluating attitudes toward infant feeding among women living with HIV; completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-11-14Clinical Trial Update: HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection [Phase 3]
Phase 3 trial update on switching HIV therapy followed by Hepatitis C treatment in people co-infected with HIV and Hepatitis C; completed st…
-
CLINICAL_TRIALS trial_result · 2022-10-24Clinical Trial Update: Study of Dapivirine Vaginal Ring (VR) in Adolescents [Phase 2]
Phase 2 study of the dapivirine vaginal ring in adolescents with HIV completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-24Clinical Trial Update: Perturbing of HIV Reservoir With Immune Stimulation [NA]
A completed clinical trial investigating immune stimulation to perturb the HIV reservoir, with results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-02Clinical Trial Update: Positive Health Check Evaluation Trial [NA]
A completed clinical trial evaluation in HIV-positive individuals with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Romidepsin Plus 3BNC117 Phase 2a Study [Phase 2]
Phase 2a study evaluating romidepsin plus 3BNC117 in HIV completed with results posted in 2022.
-
FDA approval · 2022-03-23FDA Approved: CABENUVA — Supplemental Application (ViiV Healthcare Company)
FDA has approved a supplemental application for CABENUVA (cabotegravir and rilpivirine) submitted by ViiV Healthcare Company.
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Safety and Efficacy Study of Vaccine Schedule With Ad26.Mos.HIV and MVA-Mosaic in Human Immunodeficiency Virus (HIV)-Infected Adults [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and immunogenicity of a vaccine schedule using Ad26.Mos.HIV and MVA-Mosaic in HIV-infected adults…
-
CLINICAL_TRIALS trial_result · 2022-02-16Clinical Trial Update: Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH) [Phase 4]
Phase 4 trial update for a mobile smoking cessation intervention among veterans with HIV; results have been posted.
-
CLINICAL_TRIALS trial_result · 2022-01-06Clinical Trial Update: The Effect of Ixazomib on the Latent HIV Reservoir [Phase 1, Phase 2]
Phase 1/2 trial evaluating ixazomib for reducing the latent HIV reservoir; results posted after completion.
-
FDA approval · 2021-12-20FDA Approved: APRETUDE — Original Application (ViiV Healthcare Company)
FDA approved APRETUDE (cabotegravir) for HIV pre-exposure prophylaxis (PrEP) to reduce the risk of acquiring HIV-1 infection in adults and i…
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: Dexamethasone in Cryptococcal Meningitis [Phase 2]
Phase 2 trial update on dexamethasone for cryptococcal meningitis, completed.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults [Phase 1]
Phase 1 trial update on an HIV-1 vaccine (VRC-HIVRGP096-00-VP) with alum in healthy adults, focusing on dose, safety, tolerability, and immu…
-
CLINICAL_TRIALS trial_result · 2021-08-06Clinical Trial Update: Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC [Phase 3]
Open-label Phase 3 trial comparing ATV/RTV+3TC versus ATV/RTV+TDF/FTC in treatment-naïve HIV patients, followed by ATV/RTV+3TC; study termin…
-
CLINICAL_TRIALS research · 2021-05-06Clinical Trial Update: Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV [Phase 4]
Phase 4 trial assessing safety and immunogenicity of meningococcal and pneumococcal vaccination in adults living with HIV.
-
CLINICAL_TRIALS trial_result · 2021-04-12Clinical Trial Update: Improving HIV and Alcohol-Related Outcomes Among HIV+ Persons in Clinic Settings [NA]
A completed clinical trial evaluating HIV and alcohol-related outcomes in HIV-positive individuals in clinic settings; results posted in 202…
-
FDA approval · 2021-03-19FDA Approved: FOSAMPRENAVIR CALCIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for fosamprenavir calcium from Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention Study [Phase 2]
Phase 2 trial comparing statin versus aspirin treatment intervention in HIV+ individuals on ART, completed with results posted.
-
CLINICAL_TRIALS research · 2020-09-03Clinical Trial Update: Information Visualizations to Facilitate HIV-related Patient-provider Communication (Info Viz: HIV) [NA]
Clinical trial update describing information visualizations to facilitate HIV-related patient-provider communication; results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-24Clinical Trial Update: Effect of Evolocumab on Coronary Endothelial Function [Phase 2]
Phase 2 clinical trial evaluating evolocumab's effect on coronary endothelial function in adults with HIV and coronary artery disease has co…
-
CLINICAL_TRIALS research · 2020-03-04Clinical Trial Update: Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART [Phase 4]
Phase 4 trial examining immune reconstitution and reduced immune activation with darunavir-based ART in HIV infection.
-
FDA label_change · 2019-10-03FDA Approved: TYBOST — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Tybost (cobicistat) from Gilead, resulting in changes to the product labeling.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS [NA]
A completed CHAMPS study investigating chronic hepatitis C management to improve outcomes, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-07-24Clinical Trial Update: Atazanavir/r + Lamivudine Dual Therapy [Phase 4]
Phase 4 clinical trial update of Atazanavir/ritonavir plus Lamivudine as dual therapy for HIV has completed.